Dang Y - Search Results

1

Facile Semiconductor p-n Homojunction Nanowires with Strategic p-Type Doping Engineering Combined with Surface Reconstruction for Biosensing Applications.

Li L, Fang S, Chen W, Li Y, Vafadar MF, Wang D, Kang Y, Liu X, Luo Y, Liang K, Dang Y, Zhao L, Zhao S, Yin Z, Sun H. Li L, et al. Among authors: dang y. Nanomicro Lett. 2024 May 14;16(1):192. doi: 10.1007/s40820-024-01394-5. Nanomicro Lett. 2024. PMID: 38743197 Free PMC article.

2

Developments of Anticoagulants and New Agents with Anti-Coagulant Effects in Deep Vein Thrombosis.

Dang YP, Chen YF, Li YQ, Zhao L. Dang YP, et al. Mini Rev Med Chem. 2017;17(4):338-350. doi: 10.2174/1389557516666160609083649. Mini Rev Med Chem. 2017. PMID: 27292781 Review.

3

Agent in Urgent Need of Clinical Practice: Corilagin.

Wang X, Fisher D, Pronyuk K, Dang Y, Zhao L. Wang X, et al. Among authors: dang y. Mini Rev Med Chem. 2023;23(16):1642-1652. doi: 10.2174/1389557523666230112110317. Mini Rev Med Chem. 2023. PMID: 36635908 Review.

4

Prognostic Value of Serum Ferritin for Patients with Severe Fever with Thrombocytopenia Syndrome: A Single-Center Retrospective Cohort Study.

Xie J, Su M, Dang Y, Zhao L. Xie J, et al. Among authors: dang y. Infect Dis Ther. 2023 Mar;12(3):979-988. doi: 10.1007/s40121-023-00784-3. Epub 2023 Mar 8. Infect Dis Ther. 2023. PMID: 36884213 Free PMC article.

5

Dihydromyricetin: an emerging compound with comprehensive effects on multiple systems.

He C, Chen Y, Xie J, Luo M, Fisher D, Hien NTT, Musabaev E, Dang Y, Zhao L, Xia Y. He C, et al. Among authors: dang y. Front Pharmacol. 2025 Jan 3;15:1488003. doi: 10.3389/fphar.2024.1488003. eCollection 2024. Front Pharmacol. 2025. PMID: 39830336 Free PMC article. Review.

6

Corilagin Counteracts IL-13Rα1 Signaling Pathway in Macrophages to Mitigate Schistosome Egg-Induced Hepatic Fibrosis.

Li YQ, Chen YF, Dang YP, Wang Y, Shang ZZ, Ma Q, Wang YJ, Zhang J, Luo L, Li QQ, Zhao L. Li YQ, et al. Among authors: dang yp. Front Cell Infect Microbiol. 2017 Oct 18;7:443. doi: 10.3389/fcimb.2017.00443. eCollection 2017. Front Cell Infect Microbiol. 2017. PMID: 29094025 Free PMC article.

7

Corilagin Ameliorates Atherosclerosis in Peripheral Artery Disease via the Toll-Like Receptor-4 Signaling Pathway in vitro and in vivo.

Li Y, Wang Y, Chen Y, Wang Y, Zhang S, Liu P, Chen Z, Song P, Luo L, Luo Y, Dang Y, Zhao L. Li Y, et al. Among authors: dang y. Front Immunol. 2020 Aug 6;11:1611. doi: 10.3389/fimmu.2020.01611. eCollection 2020. Front Immunol. 2020. PMID: 32849545 Free PMC article.

8

The History of Controlling and Treating Infectious Diseases in Ancient China.

Liu CL, Zhou T, Cheng LB, Fisher D, Pronyuk K, Musabaev E, Dang YP, Zhao L. Liu CL, et al. Curr Med Sci. 2024 Feb;44(1):64-70. doi: 10.1007/s11596-024-2831-0. Epub 2024 Feb 23. Curr Med Sci. 2024. PMID: 38393523 Review.

9

Therapeutic potential of natural products in schistosomiasis-associated liver fibrosis.

Liu C, Fisher D, Pronyuk K, Musabaev E, Thu Hien NT, Dang Y, Zhao L. Liu C, et al. Among authors: dang y. Front Pharmacol. 2024 May 6;15:1332027. doi: 10.3389/fphar.2024.1332027. eCollection 2024. Front Pharmacol. 2024. PMID: 38770001 Free PMC article. Review.

10

Corilagin alleviates atherosclerosis by inhibiting NLRP3 inflammasome activation via the Olfr2 signaling pathway in vitro and in vivo.

Mao J, Chen Y, Zong Q, Liu C, Xie J, Wang Y, Fisher D, Hien NTT, Pronyuk K, Musabaev E, Li Y, Zhao L, Dang Y. Mao J, et al. Among authors: dang y. Front Immunol. 2024 May 13;15:1364161. doi: 10.3389/fimmu.2024.1364161. eCollection 2024. Front Immunol. 2024. PMID: 38803504 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,097 results

Search Page

Filters